Ionox 330
CAS No. 1709-70-2
Ionox 330( Ahydol | Antioxidant 330 | Antioxidant 40 | AO-40 | BRN 2034522 )
Catalog No. M27111 CAS No. 1709-70-2
Ionox 330 is an alkylphenol compound used as an antioxidant.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | 642 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIonox 330
-
NoteResearch use only, not for human use.
-
Brief DescriptionIonox 330 is an alkylphenol compound used as an antioxidant.
-
DescriptionIonox 330 is an alkylphenol compound used as an antioxidant.
-
In Vitro——
-
In Vivo——
-
SynonymsAhydol | Antioxidant 330 | Antioxidant 40 | AO-40 | BRN 2034522
-
PathwayOthers
-
TargetOther Targets
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1709-70-2
-
Formula Weight775.215
-
Molecular FormulaC54H78O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1c(Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)c(C)c(Cc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)c(C)c1Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mofeed J, Mosleh YY. Toxic responses and antioxidative enzymes activity of Scenedesmus obliquus exposed to fenhexamid and atrazine, alone and in mixture. Ecotoxicol Environ Saf. 2013 Sep;95:234-40.
molnova catalog
related products
-
AUNP-12 TFA (1353563...
AUNP-12 TFA (NP-12 TFA) is a polypeptide antagonist in the pd-1 signaling pathway, which has the same antagonistic effect on pd-l1 and pd-l2, and can protect the proliferation and effector function of lymphocytes.
-
fulvotomentoside A
Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.
-
Mezagitamab
Mezagitamab (TAK-079) is a fully humanized IgG1λ monoclonal antibody against CD38 with high affinity for CD38-expressing cells (including plasma mother cells, plasma cells, and natural killer cells).
Cart
sales@molnova.com